10x Genomics Inc Revenue Growth Rates (TXG), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
10x Genomics Inc   (NASDAQ: TXG)
 

TXG's Revenue Growth by Quarter and Year

10x Genomics Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/TXG/growth
https://api.csimarket.com/api/v1/companies/TXG/fundamentals
https://api.csimarket.com/api/v1/companies/TXG/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
TXG Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 150.67
2nd Quarter June 151.04
1st Quarter March 150.18
FY 451.89

TXGs Annual Revenue
10x Genomics Inc 's Revenue in the fiscal year 2025 $ 641.88 millions
10x Genomics Inc 's Revenue in the fiscal year 2024 $ 610.48 millions
10x Genomics Inc 's Revenue in the fiscal year 2023 $ 618.73 millions
10x Genomics Inc 's Revenue in the fiscal year 2022 $ 516.41 millions
10x Genomics Inc 's Revenue in the fiscal year 2021 $ 490.49 millions




TXG Revenue third quarter 2026 Y/Y Growth Comment
10x Genomics Inc reported Revenue growth of 1.59% year on year in the third quarter 2026, to $ 150.67 millions, this is lower than 10x Genomics Inc 's recent average Revenue rise of 46.33%.

Looking into third quarter 2026 results within Laboratory Analytical Instruments industry 9 other companies have achieved higher Revenue growth. While 10x Genomics Inc ' s Revenue increase of 1.59% ranks overall at the positon no. 2242 in the third quarter 2026.


TXG Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 1.59 %
2nd Quarter June -12.23 %
1st Quarter March -2.76 %
FY   -

Financial Statements
10x Genomics Inc 's third quarter 2026 Revenue $ 150.67 millions TXG's Income Statement
10x Genomics Inc 's third quarter 2025 Revenue $ 148.31 millions Quarterly TXG's Income Statement


TXG Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -0.25 %
2nd Quarter June 0.57 %
1st Quarter March -10.1 %
FY (Year on Year)   -


Back to TXG Growth rate Comparisons >> Back to TXG Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #10
Healthcare Sector #325
Overall #2242

Revenue Y/Y Growth Statistics
High Average Low
266.11 % 46.33 % -0.23 %
(Sep 30 2021)  
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #10
Healthcare Sector #325
Overall #2242
Revenue Y/Y Growth Statistics
High Average Low
266.11 % 46.33 % -0.23 %
(Sep 30 2021)  

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

10x Genomics Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
67.39 % 7.22 % -40.33 %
(Sep 30 2020)  


TXG's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 10x Genomics Inc disclosed decrease in Revenue from the second quarter by -0.25% to $ 150.67 millions, from $ 151.04 millions achived in the previous reporting period.

But that's not important problem, as 10x Genomics Inc 's Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 5 other companies have achieved higher Revenue quarter on quarter growth. While 10x Genomics Inc 's Revenue growth quarter on quarter, overall rank is 1665.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #6
Healthcare Sector #224
Overall #1665
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #6
Healthcare Sector #224
Overall #1665
Revenue Q/Q Growth Statistics
High Average Low
67.39 % 7.22 % -40.33 %
(Sep 30 2020)  


TXG's III. Quarter Q/Q Revenue Comment
In the III. Quarter 2026 10x Genomics Inc disclosed decrease in Revenue from the second quarter by -0.25% to $ 150.67 millions, from $ 151.04 millions achived in the previous reporting period.

But that's not important problem, as 10x Genomics Inc 's Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 5 other companies have achieved higher Revenue quarter on quarter growth. While 10x Genomics Inc 's Revenue growth quarter on quarter, overall rank is 1665.


10x Genomics Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 616.57
Y / Y Revenue Growth (TTM) -4.05 %
Year on Year Revenue Growth Overall Ranking # 2479
Seqeuential Revenue Change (TTM) -3.3 %
Seq. Revenue Growth (TTM) Overall Ranking # 2160


Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 10x Genomics Inc reported a decrease in Revenue by -4.05% year on year, to $617 millions, compare to the 2.25% growth at Mar 31 2026.

In the Healthcare sector 358 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1323 to 2479.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 9
Healthcare Sector # 359
Overall # 2479

Revenue TTM Y/Y Growth Statistics
High Average Low
266.11 %
 46.33 %
-0.23 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 315
S&P 500 # 2160
Cumulative Revenue growth Comment
For the 12 months ended Jun 30 2026 10x Genomics Inc reported a decrease in Revenue by -4.05% year on year, to $617 millions, compare to the 2.25% growth at Mar 31 2026.

In the Healthcare sector 358 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 1323 to 2479.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 9
Healthcare Sector # 359
Overall # 2479

Revenue TTM Y/Y Growth Statistics
High Average Low
266.11 %
46.33 %
-0.23 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 9
Sector # 315
S&P 500 # 2160




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TXG's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue decrease for the quarter ending Sep 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Integra Lifesciences Holdings Corp2.27%$ 2.268 millions
Align Technology inc 1.97%$ 1.966 millions
Pediatrix Medical Group Inc 1.72%$ 1.724 millions
Lantheus Holdings Inc 1.71%$ 1.708 millions
10x Genomics Inc 1.59%$ 1.591 millions
Bruker Corporation1.58%$ 1.581 millions
Boston Scientific Corporation1.44%$ 1.441 millions
Orthofix Medical Inc 1.14%$ 1.138 millions
Puma Biotechnology Inc 1.07%$ 1.067 millions
3m Company1.03%$ 1.028 millions


About 10x Genomics Inc Revenue Growth Rates (TXG), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: 10X Genomics Inc (CIK 1770787).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-071199
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: 10X Genomics Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.